Autologous platelet lysate product versus placebo in patients with chronic leg ulcerations: A pilot study using a randomized, double-blind, placebo-controlled trial

Wounds

Volumn 16, Issue 9, 2004, Pages 273-282

  Weed, Brent ^a   Davis, Mark D P ^b,d   Felty, Cindy L ^c   Liedl, David A ^c   Pineda, Alvaro A ^d   Moore, S Breanndan ^d   Rooke, Thom W ^c  

^a UNIVERSITY OF NEVADA   (United States)

^b Department of Dermatology ^*  (United States)

^c Gonda Vascular Center   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; PLACEBO;

ADULT; AGED; ARTICLE; AUTOLOGOUS PLATELET LYSATE; CELL LYSATE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; EPITHELIZATION; FEMALE; HUMAN; LEG ULCER; MALE; MEDICAL PHOTOGRAPHY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN ULCER; THROMBOCYTE; THROMBOCYTE POOR PLASMA; TIME; TREATMENT OUTCOME; WOUND CARE; WOUND HEALING;

EID: 7044233262     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bennett NT, Schultz GS. Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg 1993;166:74-81.
2. Cohen IK, McCoy BJ, Diegelmann RF. An update on wound healing. Ann Plast Surg 1979;3:264-72.
3. Clark RA, Folkvord JM, Hart CE, Murray MJ, McPherson JM. Platelet isoforms of platelet-derived growth factor stimulate fibroblasts to contract collagen matrices. J Clin Invest 1989;84:1036-40.
4. Cromack DT, Porras-Reyes B, Mustoe TA. Current concepts in wound healing: Growth factor and macrophage interaction. J Trauma 1990;30(Suppl):S129-S133.
5. Falanga V. Growth factors and wound healing. J Dermatol Surg Oncol 1993;19:711-4.
6. Knighton DR, Hunt TK, Thakral KK, Goodson WH III. Role of platelets and fibrin in the healing sequence: An in vivo study of angiogenesis and collagen synthesis. Ann Surg 1982;196:379-88.
7. Herouy Y, Mellios P, Bandemir E, et al. Autologous platelet-derived wound healing factor promotes angiogenesis via alphavbeta3-integrin expression in chronic wounds. Int J Mol Med 2000;6:515-9.
8. Knighton DR, Ciresi K, Fiegel VD, Schumerth S, Butler E, Cerra F. Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet 1990;170:56-60.
9. Steed DL, Goslen JB, Holloway GA, Malone JM, Bunt TJ, Webster MW. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care 1992;15:1598-604.
10. Knighton DR, Ciresi KF, Fiegel VD, Austin LL, Butler EL. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 1986;204:322-30.
11. Atri SC, Misra J, Bisht D, Misra K. Use of homologous platelet factors in achieving total healing of recalcitrant skin ulcers. Surgery 1990;108:508-12.
12. Glover JL, Weingarten MS, Buchbinder DS, Poucher RL, Deitrick GA III, Fylling CP. A 4-year outcome-based retrospective study of wound healing and limb salvage in patients with chronic wounds. Adv Wound Care 1997;10:33-8.
13. Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA. Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 2001;24:483-8.
14. Keyser JE. Diabetic wound healing and limb salvage in an outpatient wound care program. South Med J 1993;86:311-7.
15. Krupski WC, Reilly LM, Perez S, Moss KM, Crombleholme PA, Rapp JH. A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: A preliminary report. J Vasc Surg 1991;14:526-32.
16. Stacey MC, Mata SD, Trengove NJ, Mather CA. Randomised double-blind placebo controlled trial of topical autologous platelet lysate in venous ulcer healing. Eur J Vasc Endovasc Surg 2000;20:296-301.
17. Halling VW, Pineda AA, Felty C, Rooke TW. Experience with autologous platelet-derived wound healing factor (abstract). Transfusion 1993;33(Suppl):28S.
18. Steed DL, Edington H, Moosa HH, Webster MW. Organization and development of a university multidisciplinary wound care clinic. Surgery 1993;114:775-8.
19. Rees RS, Robson MC, Smiell JM, Perry BH. Becaplermin gel in the treatment of pressure ulcers: A phase II randomized, double-blind, placebo-controlled study. Wound Repair Regen 1999;7:141-7.
20. Robson MC, Phillips LG, Thomason A, Robson LE, Pierce GF. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet 1992;339:23-5.
21. Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993;101:64-8.
22. Bullen EC, Longaker MT, Updike DL, et al. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol 1995;104:236-40.
23. Vaalamo M, Weckroth M, Puolakkainen P, et al. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol. 1996;135:52-9.
24. Trengove NJ, Stacey MC, MacAuley S, et al. Analysis of the acute and chronic wound environments: The role of proteases and their inhibitors. Wound Repair Regen 1999;7:442-52.